Building Capacity in Infection Prevention and Antimicrobial Stewardship in Low- and Middle-Income Countries: the Role of Partnerships Inter-countries
Antimicrobial resistance is increasing globally at a rapid pace, and patients in low- and middle-income countries are at high risk. The need for inter-country partnerships with the ultimate goal of building capacity in the fields of infection prevention and antimicrobial stewardship in these settings is of utmost importance. Reciprocal, long-term, supported relationships between collaborators from low- and middle-income countries and high-income countries will have high benefit to all partners. This paper looks at recent literature in antimicrobial stewardship and infection prevention and offers recommendations for building sustainable partnerships benefitting all collaborators working to reduce antimicrobial resistance.
KeywordsAntimicrobial resistance Antimicrobial stewardship Infection control and prevention International partnerships Low- and middle-income countries Capacity building
Compliance with Ethical Standards
Conflict of interest
Tyler Prentiss declares that he has no conflict of interest. Kate Weisberg declares that she has no conflict of interest. John Zervos declares that he has no conflict of interest.
Human and animal rights and informed consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.•• Cox JA, Vlieghe E, Mendelson M, Wertheim H, Ndegwa L, Villegas MV, et al. Antibiotic stewardship in low-and middle-income countries: same, but different? Clin Microbiol Infect. 2017;23(11):812–8. https://doi.org/10.1016/j.cmi.2017.07.010.A very recent look at antimicrobial stewardship programs in low- and middle-income countries. Looks and classifies different implementations of AMS programs in low- and middle-income countries.
- 2.• Tiong JJ, Loo JS, Mai CW. Global antimicrobial stewardship: a closer look at the formidable implementation challenges. Front Microbiol. 2016;7:1860. https://doi.org/10.3389/fmicb.2016.01860.A recent overview of the difficulties seen in implementation of global AMS work.
- 3.Outterson K, Rex JH, Jinks T, Jackson P, Hallinan J, Karp S, et al. Accelerating global innovation to address antibacterial resistance: introducing CARB-X. Nat Rev Drug Discov. 2016;15(9):589–90. https://doi.org/10.1038/nrd.2016.155.
- 4.Technological challenges in antibiotic discovery and development: a workshop summary. The National Academies Collection: reports funded by National Institutes of Health. Washington (DC) 2014.Google Scholar
- 5.Pulcini C, Morel CM, Tacconelli E, Beovic B, de With K, Goossens H, et al. Human resources estimates and funding for antibiotic stewardship teams are urgently needed. Clin Microbiol Infect. 2017;23(11):785–7. https://doi.org/10.1016/j.cmi.2017.07.013.
- 9.World Health Organization. At UN, global leaders commit to act on antimicrobial resistance. New York. 2016. http://www.who.int/mediacentre/news/releases/2016/commitment-antimicrobial-resistance/en/. Accessed 2017 August.
- 10.Drugs for Neglected Diseases Initiative. Global Antibiotic Research and Development Partnership (GARDP) 2016. https://www.dndi.org/diseases-projects/gardp/.
- 11.Global Antibiotic Resistance Partnership—India Working G. Rationalizing antibiotic use to limit antibiotic resistance in India(+). Indian J Med Res. 2011;134(3):281–94.Google Scholar
- 12.Nguyen KV, Thi Do NT, Chandna A, Nguyen TV, Pham CV, Doan PM, et al. Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam. BMC Public Health. 2013;13(1):1158. https://doi.org/10.1186/1471-2458-13-1158.
- 15.Hernandez-Gomez C, Motoa G, Vallejo M, Blanco VM, Correa A, de la Cadena E, et al. Introduction of software tools for epidemiological surveillance in infection control in Colombia. Colomb Med (Cali). 2015;46(2):60–5.Google Scholar
- 17.• Bebell LM, Muiru AN. Antibiotic use and emerging resistance: how can resource-limited countries turn the tide? Glob Heart. 2014;9(3):347–58. https://doi.org/10.1016/j.gheart.2014.08.009.A review article that discusses the level of antimicrobial resistance in low- and middle-income countries which offersrecommendations and a "road map for the future.
- 21.World Health Organization. Driving change in antimicrobial stewardship in a low-resource setting. 2017.Google Scholar
- 22.Sastry S, Masroor N, Bearman G, Hajjeh R, Holmes A, Memish Z, et al. The 17th International Congress on Infectious Diseases workshop on developing infection prevention and control resources for low- and middle-income countries. Int J Infect Dis. 2017;57:138–43. https://doi.org/10.1016/j.ijid.2017.01.040.
- 29.Cantas L, Shah SQ, Cavaco LM, Manaia CM, Walsh F, Popowska M, et al. A brief multi-disciplinary review on antimicrobial resistance in medicine and its linkage to the global environmental microbiota. Front Microbiol. 2013;4:96. https://doi.org/10.3389/fmicb.2013.00096.CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Shafiq N, Praveen Kumar M, Gautam V, Negi H, Roat R, Malhotra S, et al. Antibiotic stewardship in a tertiary care hospital of a developing country: establishment of a system and its application in a unit-GASP Initiative. Infection. 2016;44(5):651–9. https://doi.org/10.1007/s15010-016-0913-z.
- 31.World Health Organization. Antimicrobial resistance. Geneva, Switzerland. 2016. http://www.who.int/mediacentre/factsheets/fs194/en/. Accessed August 2017.
- 33.• Shallcross LJ, Howard SJ, Fowler T, Davies SC. Tackling the threat of antimicrobial resistance: from policy to sustainable action. Philos Trans R Soc Lond Ser B Biol Sci. 2015;370(1670):20140082. https://doi.org/10.1098/rstb.2014.0082.A UK-specific look at how to impact antimicrobial resistance; while all of the lessons repeated in the artcile are not directly applicable to persons in low- and middle-income countries, it highlights the importance for people at all levels to be involved in AMS.
- 34.Gilchrist M, Wade P, Ashiru-Oredope D, Howard P, Sneddon J, Whitney L, et al. Antimicrobial stewardship from policy to practice: experiences from UK antimicrobial pharmacists. Infect Dis Ther. 2015;4(Suppl 1):51–64. https://doi.org/10.1007/s40121-015-0080-z.
- 35.VanDeusen Lukas C, Koppelman E, Ostrowsky B, Sumer Z, Jalon H, Araujo C et al. Developing the capacity to implement antimicrobial stewardship: opportunities for the future. In: Battles J, Cleeman J, Kahn K, Weinberg D, editors. Advances in the prevention and control of HAIs. Rockville, MD 2014.Google Scholar
- 36.Renwick MJ, Simpkin V, Mossialos E. Targeting innovation in antibiotic drug discovery and development: the need for a one health-one Europe-one world framework. Copenhagen: WHO Health Policy Series; 2016.Google Scholar
- 38.Rogers E. Diffusion of innovations. New York, NY: Simon and Schuster; 2003.Google Scholar
- 42.•• Harris M, Weisberger E, Silver D, Macinko J. ‘They hear “Africa” and they think that there can’t be any good services’—perceived context in cross-national learning: a qualitative study of the barriers to reverse innovation. Glob. Health. 2015;11.A look at reverse innovation and the importace of collaboration across cultures and the exchange of ideas.Google Scholar
- 43.• King A, Cresswell KM, Coleman JJ, Pontefract SK, Slee A, Williams R, et al. Investigating the ways in which health information technology can promote antimicrobial stewardship: a conceptual overview. J R Soc Med. 2017;110(8):320–9. https://doi.org/10.1177/0141076817722049.A primer on how health IT opportunities have the ability to make impact on antimcirobial stewardship around the world.
- 45.Wentzel J, van Velsen L, van Limburg M, de Jong N, Karreman J, Hendrix R, et al. Participatory eHealth development to support nurses in antimicrobial stewardship. BMC Med Inform Decis Mak. 2014;14(1):45. https://doi.org/10.1186/1472-6947-14-45.